Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 12 OC17

SFE2006 Oral Communications Pituitary, ovary and steroids (8 abstracts)

Prolactinomas: all in the family?

S Razvi1, S Ashwell1, M Korbonits3, R Quinton2 & R Quinton1

1Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom; 2University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; 3Barts and the London Medical School, London, United Kingdom.


To report and discuss a kindred with pathological hyperprolactinaemia.

Case 1 (Proband)

A 39-year old man presented in June 2003 with 3-years of erectile dysfunction (ED) and was found to have hyperprolactinaemic hypogonadotrophic hypogonadism: LH 1.0 & FSH 1.5 U/L, Testosterone 5.8 nmol/L, PRL 4154 mU/L. Pituitary function was otherwise normal. MRI demonstrated an intrasellar macroadenoma. Cabergoline therapy normalised PRL and testosterone levels, with resolution of ED and significant tumour shrinkage over a period of 4 months.

Case 2

In October 2004, his 17-year-old son was referred with severe pubertal delay (G3, P2–3, A1; Testes 8 ml bilaterally), consistent with his biochemistry (LH 1.6 & FSH 3.1 U/L, testosterone 2.3 nmol/L). Although baseline PRL was elevated at 768, rising to 1009 mIU/L after several months of low-dose testosterone therapy, pituitary MRI was normal. He commenced cabergoline therapy, is currently progressing through puberty and repeat MRI is awaited.

Case 3

In March 2005, his 22-year old niece was referred with secondary amenorrhoea and galactorrhoea and was found to have hyperprolactinaemic hypogonadotrophic hypogonadism: LH <1.0 & FSH 3.9 U/L, E2 <60 pmol/L, PRL 1606 mU/L. MRI revealed a pituitary microadenoma and she was commenced on cabergoline, following which PRL level normalised, galactorrhoea resolved and periods normalised. MRI scan 8 months later showed some tumour shrinkage.


Familial pituitary tumours are seen in MEN 1 (MEN1N screen negative in this kindred), Carney complex and McCune-Albright syndrome. More recently, a syndrome of familial isolated pituitary adenomas has been recognised. Though hyperprolactinaemia is a relatively common endocrine disease, published kindreds are surprisingly rare. All 3 members of this kindred remained in touch, lived in the same town, shared the same GP and were referred to the same Endocrinologist within a 20 month timeframe. With society and healthcare becoming increasingly fragmented, such familial associations can all too easily be missed.

Volume 12

197th Meeting of the Society for Endocrinology

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts